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182a Sunday, March 1, 2009a novel oxygen sensing mechanism of cardiac L-type Ca channels which is in-
dependent of mitochondrial ROS and is partially regulated by PKA phosphor-
ylation in the left ventricle. When oxygen pressure was locally decreased from
150 to 5 mmHg within 50 ms, an immediate suppression (25%) occurred in
baseline Ica that maximized in 40-50 seconds. This response was inhibited by
PKA phosphorylation on the left but not the right ventricle. Inhibiting Ca de-
pendent inactivation using Ba2þ as the charge carrier, lead to 40% suppression
of IBa within the first 5-15s of exposure. This effect was independent of PKA
phosphorylation and equally affected both ventricles. Inhibiting SR Ca release
with 5uM thapsigargin did not mimic the response seen with Ba2þ. However,
inhibiting Calmodulin using CaM inhibitory peptide 290-309 partially sup-
pressed phosphorylated Ica in the left ventricle. This effect was also present
in HEK 293 cells expressing all subunits of the recombinant L-type Ca channel.
Furthermore, mutating 80 amino acids in the Ca binding/IQ domain of the alpha
1C subunit which removes Ca dependent inactivation and leads to similar kinet-
ics of IBa and ICa, abolished the suppression of IBa under low O2. Based on these
observations we propose that Cardiac L-type channels have oxygen sensing
properties and that Ca/Calmodulin binding domain is a key site in this process.
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BACKGROUND: Calcium regulation is important for cardiac myocyte func-
tion and cardiac development. For example, calcium channel blockade and de-
letion of calcium-regulatory proteins leads to abnormal cardiac morphogenesis.
We have previously demonstrated that deletion of the major calcium channel
isoform (CaV1.2) from the developing heart leads to grossly normal cardiac
structure, but late embryonic demise.
OBJECTIVE: Determine the effects of calcium channel deletion on cardiac de-
velopment.
METHODS: Global deletion of the major cardiac LTCC isoform, CaV1.2, was
obtained using floxed-CaV1.2 mice (Dr. Franz Hofmann) mated to beta-actin-
Cre mice. Conditional deletion of CaV1.2 in the AHF was obtained using
Mef2c-AHF-Cre mice (Dr. Brian Black). Specimens at various stages of gesta-
tion were examined by embryonic echocardiography and cardiac heart rates
and left and right ventricular shortening fractions were quantified. Embryos
were harvested and examined for changes in gross morphology and cardiac
morphology by visual observation and histological methods. Compaction of
the ventricular myocardium was quantified on histologic sections.
RESULTS: Embryos containing global or conditional deletions of CaV1.2 die at
E14 and E15, respectively.Approximately 1 day prior death, null embryos had ab-
normal cardiac function with depressed shortening fraction and abnormal heart
rates.Over the next day, cardiac failure became apparent,with evidenceof pericar-
dial effusions and body wall edema. Approximately 2 days prior to death, the
ventricularmyocardiumappeared to lackcompactionof the trabeculae into the com-
pact layer of the myocardium. Prior to this, the embryonic hearts appeared normal.
CONCLUSIONS: The presence of normal calcium channels is important for late
maturation of the embryonic ventricular myocardium. Deletion of CaV1.2
caused ventricular non-compaction followed by depressed cardiac function,
heart failure, and late embryonic demise.
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Low voltage-activated T-type Ca2þ channels (Cav3 or TTCC) play an important
role in regulating the pacemaker activities in the heart. Since adrenergic system
is critical for heart rate regulation and the TTCC is involved in cardiac rhythmn
generation, it is important to examine the regulation of the TTCC by the adren-
ergic-PKA system. In this study, we sought to resolve the question whether
Cav3.1 in cardiac myocytes is regulated by PKA.Methods: Cav3.1 a1G trans-
genic mice were established with the cardiac specific and inducible system en-
gineered by the Robbins group. Whole cell voltage clamp was used to measure
the ICa-T before and after isoproterenol application. ICa-T was also recorded with
or without cAMP (10mM) in the pipet. Results: (1) There is robust ICa-T
(25.3512.5pA/pF, n¼13) in ventricular myocytes isolated from a1G TG
mice but no ICa-T was observed in ventricular myocytes from control mice; (2)
ICa-T in a1G TGmyocytes was significantly increased by isoproterenol applica-
tion (before vs. after: 15.053.3pA/pF, n¼4 vs. 11.754.7pA/pF, n¼4, at -40mV,
p<0.05). This indicates Cav3.1 channel activity was probably up-regulated by
isoproterenol-activated PKA in myocytes isolated from adult a1G transgenic
mice. (3) cAMP can greatly increase both T-type (with vs. without cAMP:48.9529.2pA/pF, n¼4 vs. 25.3512.5pA/pF, n¼13, maximal ICa-T, p<0.05)
and L- type calcium currents (with vs. without cAMP: 19.957.4pA/pF, n¼4
vs. 7.653.7pA/pF, n¼13, maximal ICa-L, p<0.05). This further confirms the
up-regulation effect of PKA on the Cav3.1 channel activity. Conclusions: For
the first time, we found that PKA activation enhances Cav3.1 channel activity
in ventricular myocytes of mice. This finding may shed a light on the physiolog-
ical and pathophysiological (arrhythmogenic) effects of sympathetic regulation
of pacemaker activities in the heart through T-type calcium channels.
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Many diltiazem related L-VDCCblockerswere developed using amultidisciplin-
ary approach. This current studywas to investigate and compare diltiazemwith to
the newly developed compounds by mouse Langendorff-perfused heart, Ca2þ-
transients and on recombinantL-VDCC.Fiveparticular compoundswere selected
by the ligand-based virtual screening procedure (LBVS) (5B, M2, M7, M8 and
P1). Wild-type human heart and rabbit lung a1 subunits were expressed (com-
bined with the regulatory a2d and b3 subunits) in Xenopus leavis oocytes using
a two-electrode voltage clamp technique. Diltiazem is a benzothiazepine Ca2þ
channel blocker usedclinically for its antihypertensive and antiarrhythmic effects.
Previous radioligand binding assays revealed a complex interaction with the ben-
zothiazepine binding sites for M2, M7 and M8. (Carosati E. et al. J. Med Chem.
2006, 49; 5206). In agreement with this, the relative order of increased rates of
contraction and relaxation at lower concentrations (<10-6M) in un-paced hearts
was M7>M2>M8>P1. Similar increases in Ca2þ transients were observed in
cardiomyocytes. Diltiazem showed negative inotropic effects whereas 5B had
no significant effect. Diltiazem blocks Ca2þ currents in a use-dependent manner
and facilitates the channel by accelerating the inactivation and decelerating the
recovery from inactivation. In contrast to diltiazem, the new analogs had no pro-
nounced use-dependence. Application of 100 mM M8 and M2 showed ~10%
tonic block, shifted the steady-state inactivation in hyperpolarized direction and
the current inactivation time was significantly decreased compared with control
(219.6511.5 ms, 226514.5 vs. 269512.9 ms). Contrary to diltiazem, the recov-
ery from the blockbyM8andM2wascomparable to control.All of the compounds
displayed the same sensitivity on theCa2þ channel rabbit lunga1 except P1. Taken
together, these findings suggest that M8 and M2 might directly decrease the bind-
ing affinity or allowmore rapid dissociation from the benzothiazepine binding site.
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ProTxII, peptide toxin isolated from the venom of the tarantula Thrixopelma pu-
riens,modifies voltage-dependent activationofbothT-typecalcium(Ca)channels
and voltage-gated sodium (Na) channels. In the presence of ProTxII (5mM) the
voltage at halfmaximal activation (V1/2) of theCaV3.1 isoform is shifted positive
(>25mV) and maximum conductance (Gmax) decreases (~50%). Interestingly,
the toxin’s effects on this channel were completely precluded in the presence of
high extracellular divalent concentrations indicating a role for surface charge-
like, electrostatic interactionswith the channel. Severalmutant toxins inwhich in-
dividual basic residueswere neutralizedwere tested for activity onCaV3.1. Three
of thesemutants,R13Q,R22A, andK28A, significantly disrupted the ability of the
toxin to both shift channel activation and decrease Gmax. Two other mutations:
K4Q and K14A, showed minimal or no effect, thus indicating an important yet
specific role of charge in ProTxII’s interaction with CaV3.1. The gating kinetics
of T-type Ca channels varies among the three known isoforms suggesting there
might be differences in the gating structures and, therefore, potential gating mod-
ifier toxin interaction surfaces aswell. InCaV3.3, 5mMProTxII reducedGmax by
approximately 60%, similar to what was seen for CaV3.1. However, unlike in
CaV3.1, this concentration of toxin produced only a minimal shift in voltage de-
pendent activation (2mV). These results suggest significant differences in the ex-
tracellular surface of T-type Ca channels across isoforms, particularly in terms of
surface charge distribution close to one or more of the channels’ voltage sensors.
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